Articles with public access mandates - peter pappasLearn more
Available somewhere: 53
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clinical infectious diseases 46 (12), 1813-1821, 2008
Mandates: US National Institutes of Health
Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ...
Clinical infectious diseases 62 (4), e1-e50, 2016
Mandates: US National Institutes of Health
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
PG Pappas, CA Kauffman, D Andes, DK Benjamin Jr, TF Calandra, ...
Clinical infectious diseases: an official publication of the Infectious …, 2009
Mandates: US National Institutes of Health
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America
JR Perfect, WE Dismukes, F Dromer, DL Goldman, JR Graybill, RJ Hamill, ...
Clinical infectious diseases 50 (3), 291-322, 2010
Mandates: US National Institutes of Health
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
Mandates: UK Medical Research Council
Invasive candidiasis
PG Pappas, MS Lionakis, MC Arendrup, L Ostrosky-Zeichner, BJ Kullberg
Nature Reviews Disease Primers 4 (1), 1-20, 2018
Mandates: US National Institutes of Health
Combination antifungal therapy for invasive aspergillosis: a randomized trial
KA Marr, HT Schlamm, R Herbrecht, ST Rottinghaus, EJ Bow, OA Cornely, ...
Annals of internal medicine 162 (2), 81-89, 2015
Mandates: US National Institutes of Health
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of …
BH Segal, R Herbrecht, DA Stevens, L Ostrosky-Zeichner, J Sobel, ...
Clinical infectious diseases 47 (5), 674-683, 2008
Mandates: US National Institutes of Health
Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ...
Clinical Infectious Diseases 62 (4), 409-417, 2016
Mandates: US National Institutes of Health
Factors associated with mortality in transplant patients with invasive aspergillosis
JW Baddley, DR Andes, KA Marr, DP Kontoyiannis, BD Alexander, ...
Clinical Infectious Diseases 50 (12), 1559-1567, 2010
Mandates: US National Institutes of Health
Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network
SA Balajee, R Kano, JW Baddley, SA Moser, KA Marr, BD Alexander, ...
Journal of clinical microbiology 47 (10), 3138-3141, 2009
Mandates: US National Institutes of Health
Predictors of mortality and differences in clinical features among patients with Cryptococcosis according to immune status
KD Brizendine, JW Baddley, PG Pappas
PloS one 8 (3), e60431, 2013
Mandates: US National Institutes of Health
The case for adopting the “species complex” nomenclature for the etiologic agents of cryptococcosis
KJ Kwon-Chung, JE Bennett, BL Wickes, W Meyer, CA Cuomo, ...
MSphere 2 (1), 10.1128/msphere. 00357-16, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network
JW Baddley, KA Marr, DR Andes, TJ Walsh, CA Kauffman, ...
Journal of clinical microbiology 47 (10), 3271-3275, 2009
Mandates: US National Institutes of Health
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
MA Pfaller, A Espinel-Ingroff, E Canton, M Castanheira, ...
Journal of clinical microbiology 50 (6), 2040-2046, 2012
Mandates: Government of Spain
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis
PG Pappas, P Chetchotisakd, RA Larsen, W Manosuthi, MI Morris, ...
Clinical infectious diseases 48 (12), 1775-1783, 2009
Mandates: US National Institutes of Health
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
BJ Kullberg, C Viscoli, PG Pappas, J Vazquez, L Ostrosky-Zeichner, ...
Clinical Infectious Diseases 68 (12), 1981-1989, 2019
Mandates: US National Institutes of Health
Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study
S Sungkanuparph, SG Filler, P Chetchotisakd, PG Pappas, TL Nolen, ...
Clinical Infectious Diseases 49 (6), 931-934, 2009
Mandates: US National Institutes of Health
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium
MD Johnson, RE Lewis, ES Dodds Ashley, L Ostrosky-Zeichner, T Zaoutis, ...
The Journal of infectious diseases 222 (Supplement_3), S175-S198, 2020
Mandates: US National Institutes of Health
Coronavirus disease 2019–associated invasive fungal infection
JW Baddley, GR Thompson III, SCA Chen, PL White, MD Johnson, ...
Open forum infectious diseases 8 (12), ofab510, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program